左侧乳腺癌保乳术后VMAT与IMRT剂量比较的<em>Meta分析</em>

doi:10.3760/cma.j.issn.1004-4221.2018.08.013

摘要
图/表
参考文献()
相关文章 (10)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

目的对左侧乳腺癌保乳术后VMAT和IMRT靶区与OAR剂量行Meta分析。方法文献检索纳入相关研究,分析靶区和危及器官剂量参数。结果 11项研究的154病例纳入Meta分析。PTV-全乳和PTV-瘤床的 Dmean、均匀性指数均相近(P>0.05),VMAT计划中PTV-全乳、PTV-瘤床适形性指数值较IMRT计划高(P=0.000、0.002)。当靶区平均体积≤634cm³时,心脏 Dmean、V5、V20、V30,左肺 Dmean、V5、V20,右肺、右侧乳腺 Dmean均无统计学意义(P>0.05);当靶区平均体积>634 cm³时,心脏 Dmean、V5、V20 IMRT计划优于VMAT (P=0.037、0.005、0.030),V30 VMAT计划优于IMRT (P=0.001)。左肺 Dmean、V5、V20及右肺Dmea IMRT优于VMAT (P=0.013、0.000、0.000及0.001)。右侧乳腺 Dmean也相近(P>0.05)。结论 VMAT和IMRT靶区剂量分布无明显差异。对于危及器官,靶区平均体积≤634 cm³时,VMAT和IMRT受量无明显差异;靶区平均体积>634 cm³时,IMRT在心脏、肺的保护上有一定优势。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王蓓蓓
	李克新
	纪韩丹
	陈伟
	汤乐民

关键词 ：乳腺肿瘤/保乳术, 乳腺肿瘤/容积调强弧形疗法, 乳腺肿瘤/调强放射疗法, Meta分析

Abstract：

Objective To compare the dosimetric parameters of target volumes and organs at risk between volumetric-modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for left sided breast cancer after breast-conserving surgery by a meta-analysis. Methods Literature search was performed to include related studies to analyze the dosimetric parameters of target volumes and organs at risk. Results A total of 11 studies involving 154 patients were included in meta-analysis. There were no significant differences in Dmean,HI of PTV-Whole breast and PTV-Boost. Comparing to IMRT,VMAT increased the conformity index (CI) of PTV-Whole breast (P=0.000) and PTV-Boost (P=0.002).When the mean volume of target volumes was≤634 cm³,there were no significant differences in Dmean,V5,V20 of the heart and left sided lung,V30 of the heart,Dmean of the right sided lung and breast between VMAT and IMRT.When the mean volume of target volumes was>634 cm³,the Dmean(P=0.037),V5(P=0.005) and V20(P=0.030) of the heart in IMRT was lower than VMAT,but the V30(P=0.001) of heart in VMAT was lower than IMRT.IMRT showed significantly lower Dmean(P=0.013),V5(P=0.000),V20(P=0.000) of the left sided lung,and Dmean(P=0.001) of the right sided lung than VMAT.There were no significant differences in Dmean of the right sided breast. Conclusions There were no significant differences in dosimetric parameters of target volumes between VMAT and IMRT.When the mean volume of target volumes was≤634 cm³,there were no significant differences in dosimetric parameters of organs at risk. When the mean volume of target volumes was>634 cm³,IMRT has some advantages in protection of the heart and lung.

Key words： Breast neoplasms/breast-conserving surgery Breast neoplasms/volumetric-modulated arc therapy Breast neoplasms/intensity-modulated radiotherapy Meta-analysis

收稿日期: 2017-07-30

基金资助:

南通大学自然科学基金项目(15Z02)

通讯作者: 汤乐民,lemint50@ntu.edu.cn

引用本文:

王蓓蓓,李克新,纪韩丹等. 左侧乳腺癌保乳术后VMAT与IMRT剂量比较的Meta分析[J]. 中华放射肿瘤学杂志, 2018, 27(8): 775-779.

Wang Beibei,Li Kexin,Ji Handan et al. A meta-analysis comparing Dosimetric between volumetric-modulated arc therapy and intensity-modulated radiotherapy for left sided breast cancer after breast-conserving surgery[J]. Chinese Journal of Radiation Oncology, 2018, 27(8): 775-779.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.08.013 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I8/775

[1] EBCTCG (Early Breast Cancer Trialists′ Collaborative Group),McGale P,Taylor C,et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality:meta-analysis of individual patient data for 8135 women in 22 randomised trials[J].Lancet,2014,383(9935):2127-2135.DOI:10.1016/ S0140-6736(14)60488-8.
[2] Zhao H,He M,Cheng G,et al. A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT[J].Radiat Oncol, 2015,10(1):231-240.DOI:10.1186/s13014-015-0531-4.
[3] Jin GH,Chen LX,Deng XW,et al. A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques:conventional tangential field, filed-in-filed, Tangential-IMRT,Multi-beam IMRT and VMAT[J].Radiat Oncol,2013,8(1):89-96.DOI:10.1186/1748-717X-8-89.
[4] Haciislamoglu E,Colak F,Canyilmaz E,et al. Dosimetric comparison of left-sided whole-breast irradiation with 3DCRT,forward-planned IMRT,inverse-planned IMRT, helical tomotherapy,and volumetric arc therapy[J].Phys Med,2015,31(4):360-367.DOI:10.1016/j.ejmp.2015.02.005.
[5] Virén T,Heikkil J,Myllyoja K,et al. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy[J].Radiat Oncol,2015,10(1):1-8.DOI:10.1016/j.meddos.2012.04.003.
[6] 蒙渡,刘锐,王书文,等.早期左侧乳腺癌保乳术后IMRT与VMAT两种放射治疗技术的剂量学研究[J].西部医学,2016,28(11):1535-1539.DOI:10.3969/j.issn.1672-3511.2016.11.014.
Meng D,Liu R,Wang SW,et al. Comparing the radioligical dose distribution between VMAT and IMRT applied in radiotherapy of early left breast cancer patients after breast-conserving surgery[J].Med J West China,2016, 28(11):1535-1539.DOI:10.3969/j.issn.1672-3511.2016.11.014.
[7] 张旭,李凯,李娜,等.左乳腺癌保乳术后放疗不同外照射技术所致皮肤受照剂量的比较[J].现代肿瘤医学,2016,24(20):3213-3216.DOI:10.3969/j.issn.1672-4992.2016.20.011.
Zhang X,Li K,Li N,et al. Dosimetric comparison of skin dose for different techniques in left-side breast cancer radiotherapy after breast-conserving surgery[J].Mod Oncol,2016,24(20):3213-3216.DOI:10.3969/j.issn.1672-4992.2016.20.011.
[8] Badakhshi H,Kaul D,Nadobny J,et al. Image-guided volumetric modulated arc therapy for breast cancer:a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy[J].Br J Radiol,2013,86(1032):20130515.DOI:10.1259/bjr.20130515.
[9] Qi XS,Liu TX,Liu AK,et al. Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy[J].Med Dosim,2014,39(3):227-234.DOI:10.1016/j.meddos.2014.02.005.
[10] Liu ZM,Ge XL,Chen JY,et al. Adjuvant Radiotherapy after Breast Conserving Treatment for Breast Cancer:A Dosimetric Comparison between Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy[J].Asian Pac J Cancer,2015,16(8):3257-3265.DOI:10.7314/apjcp.2015.16.8.3257.
[11] Pasler M,Georg D,Bartelt S,et al. Node-positive left-sided breast cancer:does VMAT improve treatment plan quality with respect to IMRT?[J].Strahlenther Onkol,2013,189(5):380-386.DOI:10.1007/s00066-012-0281-2.
[12] Lin JF,Yeh DC,Yeh HL,et al. Dosimetric comparison of hybrid volumetric-modulated arc therapy,volumetric-modulated arc therapy,and intensity-modulated radiation therapy for left-sided early breast cancer[J].Med Dosim,2015,40(3):262-267.DOI:10.1016/j.meddos.2015.05.003.
[13] Kelemen G,Varga Z,Lázár G,et al. Cosmetic outcome 1-5 years after breast conservative surgery,irradiation and systemic therapy[J].Pathol Oncol Res,2012, 18(2):421-427.DOI:10.1007/s12253-011-9462-z.
[14] Lu SH,Cheng JC,Kuo SH,et al. Volumetric modulated arc therapy for nasopharyngeal carcinoma:a dosimetric comparison with TomoTherapy and step-and-shoot IMRT[J].Radiother Oncol,2012,104(3):324-330.DOI:10.1016/j.radonc.2011.11.017.
[15] Deng X,Han C,Chen S,et al. Dosimetric benefits of intensity-modulated radiotherapy and volumetric- modulated arc therapy in the treatment of postoperative cervical cancer patients[J].J Appl Clin Med Phys,2017,18(1):25-31.DOI:10.1002/acm².12003.
[16] Sardaro A,Petruzzelli MF,D′Errico MP,et al. Radiation-induced cardiac damage in early left breast cancer patients:Risk factors,biological mechanisms, radiobiology,and dosimetric constraints[J].Radiother Oncol,2012,103(2):133-142.DOI:10.1016/j.radonc.2012.02.008.
[17] Bonsignore A,Warburton D.Radiation Therapy and Cardiovascular Disease Risk in Breast Cancer[J].Cur Cardiova Risk Reports,2013,7(6):514-519.DOI:10.1007/s12170-013-0347-4.
[18] Mège A,Ziouèche A,Pourel N,et al.[Radiation-related heart toxicity][J].Cancer Radiother,2011,15(7):495-503.DOI:101016/j.canrad.2011.06.003.
[19] Oie Y,Saito Y, Kato M,et al. Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancer[J].Radiat Oncol,2013,8(1):1-6.DOI:10.1186/1748-717X-8-56.
[20] Lee B,Lee S,Sung J,et al. Radiotherapy-induced secondary cancer risk for breast cancer:3D conformal therapy versus IMRT versus VMAT[J].J Radiol Protect, 2014,34(2):325-331.DOI:10.1088/0952-4746/34/2/325.